Vurderingen af venstre ventrikels funktion betragtes som obligatorisk inden hver supplerende indgivelse af Myocet, når en patient overskrider den kumulative livsdosis af anthracyclin på 550 mg/ m2, eller hvor der er mistanke om cardiomyopati.
The evaluation of left ventricular function is considered mandatory before each additional administration of Myocet once a patient exceeds a lifetime cumulative anthracycline dose of 550 mg/ m2 or whenever cardiomyopathy is suspected.